Children and adolescents with HIV

The Lancet Infectious Diseases

Volumn 13, Issue 8, 2013, Pages 654-

  Binagwaho, Agnes ^a,b   Nutt, Cameron T ^c   Nsanzimana, Sabin ^d   Wagner, Claire M ^e   Mukherjee, Joia S ^b,f,g  

^a Ministry of Health of Rwanda   (Rwanda)

^b HARVARD MEDICAL SCHOOL   (United States)

^c DARTMOUTH INSTITUTE FOR HEALTH POLICY AND CLINICAL PRACTICE   (United States)

^d RWANDA BIOMEDICAL CENTER   (Rwanda)

^e Global Health Delivery Partnership   (United States)

^f PARTNERS IN HEALTH   (United States)

^g BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;

ADOLESCENT DISEASE; ANTIVIRAL THERAPY; CHILDHOOD DISEASE; HIV TEST; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LETTER; PRIORITY JOURNAL;

HIV; HIV INFECTIONS; HUMANS;

EID: 84880671293     PISSN: 14733099     EISSN: 14744457     Source Type: Journal    
DOI: 10.1016/S1473-3099(13)70188-9     Document Type: Letter

References (5)

1. Chang LW, Serwadda D, Quinn TC, Wawer MJ, Gray RH, Reynolds SJ Combination implementation for HIV prevention: moving from clinical trial evidence to population-level effects. Lancet Infect Dis 2013, 13:65-76.
2. Opportunity in crisis: preventing HIV from early adolescence to young adulthood 2011, UNICEF, United Nations Children's Fund, New York.
3. UNAIDS Report on the global AIDS epidemic 2012 2012, UNAIDS, Joint United Nations Programme on HIV/AIDS, Geneva.
4. Nachega JB, Hislop M, Nguyen H, et al. Antiretroviral therapy adherence, virologic and immunologic outcomes in adolescents compared with adults in southern Africa. J Acquir Immune Defic Syndr 2009, 51:65-71.
5. Binagwaho A, Ratnayake N The role of social capital in successful adherence to antiretroviral therapy in Africa. PLoS Med 2009, 6:e1000018.